nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—Methylprednisolone—psoriatic arthritis	0.0724	0.104	CbGbCtD
Midazolam—CYP3A7—Dexamethasone—psoriatic arthritis	0.0561	0.0806	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0561	0.0806	CbGbCtD
Midazolam—CYP2E1—Dexamethasone—psoriatic arthritis	0.0541	0.0778	CbGbCtD
Midazolam—CYP2B6—Dexamethasone—psoriatic arthritis	0.0534	0.0767	CbGbCtD
Midazolam—ABCB1—Betamethasone—psoriatic arthritis	0.0471	0.0676	CbGbCtD
Midazolam—ABCB1—Prednisolone—psoriatic arthritis	0.0464	0.0667	CbGbCtD
Midazolam—ABCB1—Prednisone—psoriatic arthritis	0.0438	0.063	CbGbCtD
Midazolam—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0434	0.0623	CbGbCtD
Midazolam—CYP3A5—Dexamethasone—psoriatic arthritis	0.0421	0.0605	CbGbCtD
Midazolam—CYP3A4—Triamcinolone—psoriatic arthritis	0.0329	0.0472	CbGbCtD
Midazolam—CYP3A4—Betamethasone—psoriatic arthritis	0.0282	0.0405	CbGbCtD
Midazolam—CYP3A4—Prednisolone—psoriatic arthritis	0.0278	0.04	CbGbCtD
Midazolam—ABCB1—Dexamethasone—psoriatic arthritis	0.0274	0.0393	CbGbCtD
Midazolam—CYP3A4—Prednisone—psoriatic arthritis	0.0263	0.0378	CbGbCtD
Midazolam—ABCB1—Methotrexate—psoriatic arthritis	0.022	0.0316	CbGbCtD
Midazolam—CYP3A4—Dexamethasone—psoriatic arthritis	0.0164	0.0236	CbGbCtD
Midazolam—Thrombophlebitis—Prednisone—psoriatic arthritis	0.00101	0.00331	CcSEcCtD
Midazolam—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.001	0.00329	CcSEcCtD
Midazolam—Osteoarthritis—Betamethasone—psoriatic arthritis	0.001	0.00329	CcSEcCtD
Midazolam—Affect lability—Dexamethasone—psoriatic arthritis	0.000985	0.00324	CcSEcCtD
Midazolam—Affect lability—Betamethasone—psoriatic arthritis	0.000985	0.00324	CcSEcCtD
Midazolam—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.000977	0.00321	CcSEcCtD
Midazolam—Psychotic disorder—Betamethasone—psoriatic arthritis	0.000977	0.00321	CcSEcCtD
Midazolam—Muscular weakness—Triamcinolone—psoriatic arthritis	0.000973	0.0032	CcSEcCtD
Midazolam—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00097	0.00319	CcSEcCtD
Midazolam—Depressed level of consciousness—Methotrexate—psoriatic arthritis	0.000969	0.00318	CcSEcCtD
Midazolam—Skin exfoliation—Methotrexate—psoriatic arthritis	0.000958	0.00315	CcSEcCtD
Midazolam—Irritability—Betamethasone—psoriatic arthritis	0.000955	0.00314	CcSEcCtD
Midazolam—Irritability—Dexamethasone—psoriatic arthritis	0.000955	0.00314	CcSEcCtD
Midazolam—Cardiac arrest—Betamethasone—psoriatic arthritis	0.000951	0.00313	CcSEcCtD
Midazolam—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.000951	0.00313	CcSEcCtD
Midazolam—Injury—Prednisone—psoriatic arthritis	0.000948	0.00312	CcSEcCtD
Midazolam—Mood swings—Dexamethasone—psoriatic arthritis	0.000948	0.00312	CcSEcCtD
Midazolam—Mood swings—Betamethasone—psoriatic arthritis	0.000948	0.00312	CcSEcCtD
Midazolam—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.000935	0.00307	CcSEcCtD
Midazolam—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.000906	0.00298	CcSEcCtD
Midazolam—Cardiac failure—Prednisone—psoriatic arthritis	0.000893	0.00293	CcSEcCtD
Midazolam—Lethargy—Prednisone—psoriatic arthritis	0.000889	0.00292	CcSEcCtD
Midazolam—Muscular weakness—Betamethasone—psoriatic arthritis	0.000883	0.0029	CcSEcCtD
Midazolam—Muscular weakness—Dexamethasone—psoriatic arthritis	0.000883	0.0029	CcSEcCtD
Midazolam—Osteoarthritis—Prednisone—psoriatic arthritis	0.000871	0.00286	CcSEcCtD
Midazolam—Affect lability—Prednisone—psoriatic arthritis	0.000858	0.00282	CcSEcCtD
Midazolam—Psychotic disorder—Prednisone—psoriatic arthritis	0.000851	0.0028	CcSEcCtD
Midazolam—Bradycardia—Prednisolone—psoriatic arthritis	0.000845	0.00278	CcSEcCtD
Midazolam—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.000841	0.00277	CcSEcCtD
Midazolam—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.000833	0.00274	CcSEcCtD
Midazolam—Irritability—Prednisone—psoriatic arthritis	0.000832	0.00273	CcSEcCtD
Midazolam—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.000831	0.00273	CcSEcCtD
Midazolam—Cardiac arrest—Prednisone—psoriatic arthritis	0.000829	0.00272	CcSEcCtD
Midazolam—Mood swings—Prednisone—psoriatic arthritis	0.000825	0.00271	CcSEcCtD
Midazolam—Visual impairment—Prednisolone—psoriatic arthritis	0.000799	0.00263	CcSEcCtD
Midazolam—Bradycardia—Triamcinolone—psoriatic arthritis	0.000777	0.00255	CcSEcCtD
Midazolam—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000775	0.00255	CcSEcCtD
Midazolam—Muscular weakness—Prednisone—psoriatic arthritis	0.000769	0.00253	CcSEcCtD
Midazolam—Visual disturbance—Methotrexate—psoriatic arthritis	0.000768	0.00253	CcSEcCtD
Midazolam—Hallucination—Methylprednisolone—psoriatic arthritis	0.000757	0.00249	CcSEcCtD
Midazolam—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000756	0.00248	CcSEcCtD
Midazolam—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000756	0.00248	CcSEcCtD
Midazolam—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.000752	0.00247	CcSEcCtD
Midazolam—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000748	0.00246	CcSEcCtD
Midazolam—Lethargy—Methotrexate—psoriatic arthritis	0.000743	0.00244	CcSEcCtD
Midazolam—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000734	0.00241	CcSEcCtD
Midazolam—Osteoarthritis—Methotrexate—psoriatic arthritis	0.000728	0.00239	CcSEcCtD
Midazolam—Erythema—Prednisolone—psoriatic arthritis	0.000722	0.00237	CcSEcCtD
Midazolam—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000711	0.00234	CcSEcCtD
Midazolam—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000706	0.00232	CcSEcCtD
Midazolam—Bradycardia—Betamethasone—psoriatic arthritis	0.000705	0.00232	CcSEcCtD
Midazolam—Bradycardia—Dexamethasone—psoriatic arthritis	0.000705	0.00232	CcSEcCtD
Midazolam—Irritability—Methotrexate—psoriatic arthritis	0.000695	0.00228	CcSEcCtD
Midazolam—Mood swings—Methotrexate—psoriatic arthritis	0.00069	0.00227	CcSEcCtD
Midazolam—Hallucination—Dexamethasone—psoriatic arthritis	0.000689	0.00226	CcSEcCtD
Midazolam—Hallucination—Betamethasone—psoriatic arthritis	0.000689	0.00226	CcSEcCtD
Midazolam—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000688	0.00226	CcSEcCtD
Midazolam—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000686	0.00225	CcSEcCtD
Midazolam—Ataxia—Methotrexate—psoriatic arthritis	0.000685	0.00225	CcSEcCtD
Midazolam—Vision blurred—Prednisolone—psoriatic arthritis	0.000681	0.00224	CcSEcCtD
Midazolam—Depression—Prednisone—psoriatic arthritis	0.00067	0.0022	CcSEcCtD
Midazolam—Visual impairment—Betamethasone—psoriatic arthritis	0.000667	0.00219	CcSEcCtD
Midazolam—Visual impairment—Dexamethasone—psoriatic arthritis	0.000667	0.00219	CcSEcCtD
Midazolam—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000667	0.00219	CcSEcCtD
Midazolam—Erythema—Triamcinolone—psoriatic arthritis	0.000664	0.00218	CcSEcCtD
Midazolam—Erythema—Methylprednisolone—psoriatic arthritis	0.000663	0.00218	CcSEcCtD
Midazolam—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000658	0.00216	CcSEcCtD
Midazolam—Vertigo—Prednisolone—psoriatic arthritis	0.000649	0.00213	CcSEcCtD
Midazolam—Syncope—Prednisolone—psoriatic arthritis	0.000648	0.00213	CcSEcCtD
Midazolam—Eye disorder—Dexamethasone—psoriatic arthritis	0.000647	0.00213	CcSEcCtD
Midazolam—Eye disorder—Betamethasone—psoriatic arthritis	0.000647	0.00213	CcSEcCtD
Midazolam—Bradycardia—Prednisone—psoriatic arthritis	0.000614	0.00202	CcSEcCtD
Midazolam—Erythema—Dexamethasone—psoriatic arthritis	0.000603	0.00198	CcSEcCtD
Midazolam—Erythema—Betamethasone—psoriatic arthritis	0.000603	0.00198	CcSEcCtD
Midazolam—Hallucination—Prednisone—psoriatic arthritis	0.0006	0.00197	CcSEcCtD
Midazolam—Vertigo—Triamcinolone—psoriatic arthritis	0.000597	0.00196	CcSEcCtD
Midazolam—Syncope—Triamcinolone—psoriatic arthritis	0.000596	0.00196	CcSEcCtD
Midazolam—Vertigo—Methylprednisolone—psoriatic arthritis	0.000595	0.00196	CcSEcCtD
Midazolam—Syncope—Methylprednisolone—psoriatic arthritis	0.000594	0.00195	CcSEcCtD
Midazolam—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000592	0.00195	CcSEcCtD
Midazolam—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000589	0.00194	CcSEcCtD
Midazolam—Shock—Prednisolone—psoriatic arthritis	0.00058	0.00191	CcSEcCtD
Midazolam—Cough—Triamcinolone—psoriatic arthritis	0.00058	0.0019	CcSEcCtD
Midazolam—Tachycardia—Prednisolone—psoriatic arthritis	0.000575	0.00189	CcSEcCtD
Midazolam—Eye disorder—Prednisone—psoriatic arthritis	0.000563	0.00185	CcSEcCtD
Midazolam—Anxiety—Methylprednisolone—psoriatic arthritis	0.000562	0.00185	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—psoriatic arthritis	0.000561	0.00184	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00056	0.00184	CcSEcCtD
Midazolam—Depression—Methotrexate—psoriatic arthritis	0.00056	0.00184	CcSEcCtD
Midazolam—Dry mouth—Triamcinolone—psoriatic arthritis	0.000553	0.00182	CcSEcCtD
Midazolam—Confusional state—Methylprednisolone—psoriatic arthritis	0.000545	0.00179	CcSEcCtD
Midazolam—Immune system disorder—Prednisone—psoriatic arthritis	0.000545	0.00179	CcSEcCtD
Midazolam—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000542	0.00178	CcSEcCtD
Midazolam—Vertigo—Betamethasone—psoriatic arthritis	0.000541	0.00178	CcSEcCtD
Midazolam—Vertigo—Dexamethasone—psoriatic arthritis	0.000541	0.00178	CcSEcCtD
Midazolam—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000541	0.00178	CcSEcCtD
Midazolam—Syncope—Betamethasone—psoriatic arthritis	0.00054	0.00178	CcSEcCtD
Midazolam—Syncope—Dexamethasone—psoriatic arthritis	0.00054	0.00178	CcSEcCtD
Midazolam—Shock—Triamcinolone—psoriatic arthritis	0.000533	0.00175	CcSEcCtD
Midazolam—Shock—Methylprednisolone—psoriatic arthritis	0.000532	0.00175	CcSEcCtD
Midazolam—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00053	0.00174	CcSEcCtD
Midazolam—Paraesthesia—Prednisolone—psoriatic arthritis	0.000529	0.00174	CcSEcCtD
Midazolam—Tachycardia—Triamcinolone—psoriatic arthritis	0.000529	0.00174	CcSEcCtD
Midazolam—Mental disorder—Prednisone—psoriatic arthritis	0.000528	0.00174	CcSEcCtD
Midazolam—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000528	0.00173	CcSEcCtD
Midazolam—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000525	0.00173	CcSEcCtD
Midazolam—Erythema—Prednisone—psoriatic arthritis	0.000525	0.00172	CcSEcCtD
Midazolam—Anxiety—Dexamethasone—psoriatic arthritis	0.000511	0.00168	CcSEcCtD
Midazolam—Anxiety—Betamethasone—psoriatic arthritis	0.000511	0.00168	CcSEcCtD
Midazolam—Hypotension—Methylprednisolone—psoriatic arthritis	0.000505	0.00166	CcSEcCtD
Midazolam—Pain—Prednisolone—psoriatic arthritis	0.000504	0.00166	CcSEcCtD
Midazolam—Vision blurred—Prednisone—psoriatic arthritis	0.000495	0.00163	CcSEcCtD
Midazolam—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000492	0.00162	CcSEcCtD
Midazolam—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000492	0.00162	CcSEcCtD
Midazolam—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000487	0.0016	CcSEcCtD
Midazolam—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000486	0.0016	CcSEcCtD
Midazolam—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000486	0.0016	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—psoriatic arthritis	0.000486	0.0016	CcSEcCtD
Midazolam—Shock—Dexamethasone—psoriatic arthritis	0.000484	0.00159	CcSEcCtD
Midazolam—Shock—Betamethasone—psoriatic arthritis	0.000484	0.00159	CcSEcCtD
Midazolam—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000483	0.00159	CcSEcCtD
Midazolam—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000482	0.00159	CcSEcCtD
Midazolam—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000482	0.00159	CcSEcCtD
Midazolam—Agitation—Prednisone—psoriatic arthritis	0.000482	0.00159	CcSEcCtD
Midazolam—Tachycardia—Betamethasone—psoriatic arthritis	0.00048	0.00158	CcSEcCtD
Midazolam—Tachycardia—Dexamethasone—psoriatic arthritis	0.00048	0.00158	CcSEcCtD
Midazolam—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000477	0.00157	CcSEcCtD
Midazolam—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000476	0.00156	CcSEcCtD
Midazolam—Vertigo—Prednisone—psoriatic arthritis	0.000471	0.00155	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—psoriatic arthritis	0.000471	0.00155	CcSEcCtD
Midazolam—Syncope—Prednisone—psoriatic arthritis	0.000471	0.00155	CcSEcCtD
Midazolam—Urticaria—Prednisolone—psoriatic arthritis	0.000468	0.00154	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000468	0.00154	CcSEcCtD
Midazolam—Fatigue—Triamcinolone—psoriatic arthritis	0.000467	0.00154	CcSEcCtD
Midazolam—Fatigue—Methylprednisolone—psoriatic arthritis	0.000466	0.00153	CcSEcCtD
Midazolam—Pain—Triamcinolone—psoriatic arthritis	0.000463	0.00152	CcSEcCtD
Midazolam—Hypotension—Betamethasone—psoriatic arthritis	0.00046	0.00151	CcSEcCtD
Midazolam—Hypotension—Dexamethasone—psoriatic arthritis	0.00046	0.00151	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—psoriatic arthritis	0.000455	0.0015	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000454	0.00149	CcSEcCtD
Midazolam—Chills—Methotrexate—psoriatic arthritis	0.000452	0.00149	CcSEcCtD
Midazolam—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000447	0.00147	CcSEcCtD
Midazolam—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000446	0.00146	CcSEcCtD
Midazolam—Anxiety—Prednisone—psoriatic arthritis	0.000445	0.00146	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000444	0.00146	CcSEcCtD
Midazolam—Paraesthesia—Betamethasone—psoriatic arthritis	0.000442	0.00145	CcSEcCtD
Midazolam—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000442	0.00145	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—psoriatic arthritis	0.000441	0.00145	CcSEcCtD
Midazolam—Erythema—Methotrexate—psoriatic arthritis	0.000439	0.00144	CcSEcCtD
Midazolam—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000434	0.00143	CcSEcCtD
Midazolam—Dyspepsia—Betamethasone—psoriatic arthritis	0.000433	0.00142	CcSEcCtD
Midazolam—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000433	0.00142	CcSEcCtD
Midazolam—Urticaria—Triamcinolone—psoriatic arthritis	0.000431	0.00142	CcSEcCtD
Midazolam—Urticaria—Methylprednisolone—psoriatic arthritis	0.00043	0.00141	CcSEcCtD
Midazolam—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000428	0.00141	CcSEcCtD
Midazolam—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000425	0.0014	CcSEcCtD
Midazolam—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000425	0.0014	CcSEcCtD
Midazolam—Fatigue—Dexamethasone—psoriatic arthritis	0.000424	0.00139	CcSEcCtD
Midazolam—Fatigue—Betamethasone—psoriatic arthritis	0.000424	0.00139	CcSEcCtD
Midazolam—Shock—Prednisone—psoriatic arthritis	0.000421	0.00138	CcSEcCtD
Midazolam—Pain—Dexamethasone—psoriatic arthritis	0.000421	0.00138	CcSEcCtD
Midazolam—Pain—Betamethasone—psoriatic arthritis	0.000421	0.00138	CcSEcCtD
Midazolam—Nervous system disorder—Prednisone—psoriatic arthritis	0.00042	0.00138	CcSEcCtD
Midazolam—Tachycardia—Prednisone—psoriatic arthritis	0.000418	0.00137	CcSEcCtD
Midazolam—Skin disorder—Prednisone—psoriatic arthritis	0.000416	0.00137	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—psoriatic arthritis	0.000413	0.00136	CcSEcCtD
Midazolam—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000405	0.00133	CcSEcCtD
Midazolam—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000405	0.00133	CcSEcCtD
Midazolam—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000399	0.00131	CcSEcCtD
Midazolam—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000398	0.00131	CcSEcCtD
Midazolam—Vertigo—Methotrexate—psoriatic arthritis	0.000394	0.0013	CcSEcCtD
Midazolam—Urticaria—Betamethasone—psoriatic arthritis	0.000391	0.00128	CcSEcCtD
Midazolam—Urticaria—Dexamethasone—psoriatic arthritis	0.000391	0.00128	CcSEcCtD
Midazolam—Dizziness—Prednisolone—psoriatic arthritis	0.00039	0.00128	CcSEcCtD
Midazolam—Asthenia—Triamcinolone—psoriatic arthritis	0.000389	0.00128	CcSEcCtD
Midazolam—Asthenia—Methylprednisolone—psoriatic arthritis	0.000388	0.00128	CcSEcCtD
Midazolam—Paraesthesia—Prednisone—psoriatic arthritis	0.000385	0.00126	CcSEcCtD
Midazolam—Pruritus—Triamcinolone—psoriatic arthritis	0.000383	0.00126	CcSEcCtD
Midazolam—Cough—Methotrexate—psoriatic arthritis	0.000383	0.00126	CcSEcCtD
Midazolam—Pruritus—Methylprednisolone—psoriatic arthritis	0.000383	0.00126	CcSEcCtD
Midazolam—Dyspepsia—Prednisone—psoriatic arthritis	0.000377	0.00124	CcSEcCtD
Midazolam—Rash—Prednisolone—psoriatic arthritis	0.000372	0.00122	CcSEcCtD
Midazolam—Dermatitis—Prednisolone—psoriatic arthritis	0.000371	0.00122	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000371	0.00122	CcSEcCtD
Midazolam—Fatigue—Prednisone—psoriatic arthritis	0.000369	0.00121	CcSEcCtD
Midazolam—Headache—Prednisolone—psoriatic arthritis	0.000369	0.00121	CcSEcCtD
Midazolam—Constipation—Prednisone—psoriatic arthritis	0.000366	0.0012	CcSEcCtD
Midazolam—Confusional state—Methotrexate—psoriatic arthritis	0.000361	0.00119	CcSEcCtD
Midazolam—Dizziness—Triamcinolone—psoriatic arthritis	0.000358	0.00118	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000358	0.00118	CcSEcCtD
Midazolam—Dizziness—Methylprednisolone—psoriatic arthritis	0.000358	0.00118	CcSEcCtD
Midazolam—Feeling abnormal—Prednisone—psoriatic arthritis	0.000353	0.00116	CcSEcCtD
Midazolam—Asthenia—Dexamethasone—psoriatic arthritis	0.000353	0.00116	CcSEcCtD
Midazolam—Asthenia—Betamethasone—psoriatic arthritis	0.000353	0.00116	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000351	0.00115	CcSEcCtD
Midazolam—Nausea—Prednisolone—psoriatic arthritis	0.00035	0.00115	CcSEcCtD
Midazolam—Pruritus—Dexamethasone—psoriatic arthritis	0.000348	0.00114	CcSEcCtD
Midazolam—Pruritus—Betamethasone—psoriatic arthritis	0.000348	0.00114	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—psoriatic arthritis	0.000348	0.00114	CcSEcCtD
Midazolam—Vomiting—Triamcinolone—psoriatic arthritis	0.000345	0.00113	CcSEcCtD
Midazolam—Vomiting—Methylprednisolone—psoriatic arthritis	0.000344	0.00113	CcSEcCtD
Midazolam—Rash—Triamcinolone—psoriatic arthritis	0.000342	0.00112	CcSEcCtD
Midazolam—Dermatitis—Triamcinolone—psoriatic arthritis	0.000341	0.00112	CcSEcCtD
Midazolam—Rash—Methylprednisolone—psoriatic arthritis	0.000341	0.00112	CcSEcCtD
Midazolam—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000341	0.00112	CcSEcCtD
Midazolam—Urticaria—Prednisone—psoriatic arthritis	0.00034	0.00112	CcSEcCtD
Midazolam—Headache—Triamcinolone—psoriatic arthritis	0.00034	0.00112	CcSEcCtD
Midazolam—Headache—Methylprednisolone—psoriatic arthritis	0.000339	0.00111	CcSEcCtD
Midazolam—Hypotension—Methotrexate—psoriatic arthritis	0.000334	0.0011	CcSEcCtD
Midazolam—Dizziness—Betamethasone—psoriatic arthritis	0.000325	0.00107	CcSEcCtD
Midazolam—Dizziness—Dexamethasone—psoriatic arthritis	0.000325	0.00107	CcSEcCtD
Midazolam—Nausea—Triamcinolone—psoriatic arthritis	0.000322	0.00106	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—psoriatic arthritis	0.000321	0.00106	CcSEcCtD
Midazolam—Nausea—Methylprednisolone—psoriatic arthritis	0.000321	0.00106	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—psoriatic arthritis	0.000319	0.00105	CcSEcCtD
Midazolam—Somnolence—Methotrexate—psoriatic arthritis	0.000318	0.00105	CcSEcCtD
Midazolam—Hypersensitivity—Prednisone—psoriatic arthritis	0.000316	0.00104	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—psoriatic arthritis	0.000315	0.00104	CcSEcCtD
Midazolam—Vomiting—Dexamethasone—psoriatic arthritis	0.000313	0.00103	CcSEcCtD
Midazolam—Vomiting—Betamethasone—psoriatic arthritis	0.000313	0.00103	CcSEcCtD
Midazolam—Rash—Dexamethasone—psoriatic arthritis	0.00031	0.00102	CcSEcCtD
Midazolam—Rash—Betamethasone—psoriatic arthritis	0.00031	0.00102	CcSEcCtD
Midazolam—Dermatitis—Dexamethasone—psoriatic arthritis	0.00031	0.00102	CcSEcCtD
Midazolam—Dermatitis—Betamethasone—psoriatic arthritis	0.00031	0.00102	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000309	0.00102	CcSEcCtD
Midazolam—Fatigue—Methotrexate—psoriatic arthritis	0.000309	0.00101	CcSEcCtD
Midazolam—Headache—Dexamethasone—psoriatic arthritis	0.000308	0.00101	CcSEcCtD
Midazolam—Headache—Betamethasone—psoriatic arthritis	0.000308	0.00101	CcSEcCtD
Midazolam—Asthenia—Prednisone—psoriatic arthritis	0.000307	0.00101	CcSEcCtD
Midazolam—Pain—Methotrexate—psoriatic arthritis	0.000306	0.00101	CcSEcCtD
Midazolam—Pruritus—Prednisone—psoriatic arthritis	0.000303	0.000996	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000295	0.000969	CcSEcCtD
Midazolam—Nausea—Dexamethasone—psoriatic arthritis	0.000292	0.00096	CcSEcCtD
Midazolam—Nausea—Betamethasone—psoriatic arthritis	0.000292	0.00096	CcSEcCtD
Midazolam—Urticaria—Methotrexate—psoriatic arthritis	0.000284	0.000935	CcSEcCtD
Midazolam—Dizziness—Prednisone—psoriatic arthritis	0.000283	0.000931	CcSEcCtD
Midazolam—Vomiting—Prednisone—psoriatic arthritis	0.000272	0.000895	CcSEcCtD
Midazolam—Rash—Prednisone—psoriatic arthritis	0.00027	0.000888	CcSEcCtD
Midazolam—Dermatitis—Prednisone—psoriatic arthritis	0.00027	0.000887	CcSEcCtD
Midazolam—Headache—Prednisone—psoriatic arthritis	0.000268	0.000882	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000264	0.000867	CcSEcCtD
Midazolam—Asthenia—Methotrexate—psoriatic arthritis	0.000257	0.000844	CcSEcCtD
Midazolam—Nausea—Prednisone—psoriatic arthritis	0.000254	0.000836	CcSEcCtD
Midazolam—Pruritus—Methotrexate—psoriatic arthritis	0.000253	0.000832	CcSEcCtD
Midazolam—Dizziness—Methotrexate—psoriatic arthritis	0.000237	0.000778	CcSEcCtD
Midazolam—Vomiting—Methotrexate—psoriatic arthritis	0.000228	0.000748	CcSEcCtD
Midazolam—Rash—Methotrexate—psoriatic arthritis	0.000226	0.000742	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—psoriatic arthritis	0.000225	0.000741	CcSEcCtD
Midazolam—Headache—Methotrexate—psoriatic arthritis	0.000224	0.000737	CcSEcCtD
Midazolam—Nausea—Methotrexate—psoriatic arthritis	0.000213	0.000699	CcSEcCtD
